IFF

International Flavors & Fragrances Inc

Add to Watchlist

Advanced Chart

66.160

-4.46(-6.315%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

74.575

Open

73.940

VWAP

66.83

Vol

5.50M

Mkt Cap

16.96B

Low

63.710

Amount

367.85M

EV/EBITDA(TTM)

14.12

Total Shares

255.35M

23.46B

EV/OCF(TTM)

21.29

P/S(TTM)

1.61

International Flavors & Fragrances Inc. is a creator and manufacturer of food, beverage, health and biosciences, scent, and complementary adjacent products. The Company's segment includes Taste, Food Ingredients, Health & Biosciences, and Scent. The Taste segment consists of a range of flavor compounds and natural taste solutions used in food and beverage applications. The Food Ingredients segment includes a broad portfolio of natural and plant-based specialty ingredients that provide texturizing and food protection capabilities, as well as soy and pea protein solutions, emulsifiers, and sweeteners. Its Health & Biosciences segment consists of the development and production of an advanced biotechnology-derived portfolio of enzymes, food cultures, probiotics and specialty ingredients for food and non-food applications. Its Scent segment creates fragrance compounds and fragrance ingredients that are integral elements in perfumes and household and personal care products.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2025Q3

FY2025Q2

2.59B

-6.68%

0.891

-8.16%

2.67B

-8.69%

1.056

+1.51%

2.70B

-6.49%

1.122

-3.3%

Estimates Revision

The market is revising Downward the revenue expectations for International Flavors & Fragrances Inc. (IFF) for FY2025, with the revenue forecasts being adjusted by -0.24% over the past three months. During the same period, the stock price has changed by -16.46%.

Revenue Estimates for FY2025

Revise Downward

-0.24%

In Past 3 Month

EPS Estimates for FY2025

Revise Downward

-4.11%

In Past 3 Month

Stock Price

Go Down

-16.46%

In Past 3 Month

11 Analyst Rating

38.51% Upside

Wall Street analysts forecast IFF stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for IFF is 91.64 USD with a low forecast of 83.00 USD and a high forecast of 105.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

10 Buy

1 Hold

0 Sell

Strong Buy

38.51% Upside

Current: 66.160

Low

83.00

Averages

91.64

High

105.00

38.51% Upside

Current: 66.160

Low

83.00

Averages

91.64

High

105.00

Tigress Financial

NULL -> Buy

initiated

$105

2025-06-04

Reason

Tigress Financial

Price Target

$105

2025-06-04

initiated

NULL -> Buy

Reason

Tigress Financial initiated coverage of IFF with a Buy rating and $105 price target. IFF is strategically positioned for long-term growth by capitalizing on the rising consumer demand for health-oriented and functional products, targeted investments, and a broad product portfolio, combined with its ongoing focus on R&D-driven opportunities and balance sheet and product portfolio optimization, the analyst tells investors.

Morgan Stanley

Lisa De Neve

Overweight

downgrade

$100 -> $98

2025-05-13

Reason

Morgan Stanley

Lisa De Neve

Price Target

$100 -> $98

2025-05-13

downgrade

Overweight

Reason

Morgan Stanley analyst Lisa De Neve lowered the firm's price target on IFF to $98 from $100 and keeps an Overweight rating on the shares. IFF offers a diversified customer and regional footprint, innovation launches and tailwinds from a meaningful regulatory wave driving reformulation, driving about three times the rate of U.S. Consumer Staples growth over FY25-26, the analyst tells investors. The firm has adjusted its model for the completed Pharma Divestment and lower projected net interest costs, leaving its FY25, FY26 and FY27 adjusted EPS forecasts 1.8%, 4.8% and 6.1% lower, respectively.

Barclays

Equal Weight -> Overweight

upgrade

$76 -> $84

2025-05-08

Reason

Barclays

Price Target

$76 -> $84

2025-05-08

upgrade

Equal Weight -> Overweight

Reason

Barclays upgraded IFF to Overweight from Equal Weight with a price target of $84, up from $76. With management reaffirming its 2025 guidance, including tariffs and encapsulating a significant economic slowdown at the low end of sales, IFF's estimates are "essentially de-risked," the analyst tells investors in a research note. The firm believes the post-earnings selloff in the stock could provide an attractive entry point.

Citi

Patrick Cunningham

Buy

maintain

$84 -> $90

2025-05-08

Reason

Citi

Patrick Cunningham

Price Target

$84 -> $90

2025-05-08

maintain

Buy

Reason

Citi analyst Patrick Cunningham raised the firm's price target on IFF to $90 from $84 and keeps a Buy rating on the shares following the earnings report. The company's order books have stayed consistent into April but management noted concerns about consumer uncertainty and cited some modest softening in consumer fragrance, the analyst tells investors in a research note.

Baird

Outperform -> NULL

downgrade

$110 -> $100

2025-05-08

Reason

Baird

Price Target

$110 -> $100

2025-05-08

downgrade

Outperform -> NULL

Reason

Baird lowered the firm's price target on IFF to $100 from $110 and keeps an Outperform rating on the shares. The firm updated its model following Q1 results where demand uncertainty weighs on sentiment.

Oppenheimer

Kristen Owen

Buy

Maintains

$104 → $89

2025-04-22

Reason

Oppenheimer

Kristen Owen

Price Target

$104 → $89

2025-04-22

Maintains

Buy

Reason

Oppenheimer lowered the firm's price target on IFF to $89 from $104 and keeps an Outperform rating on the shares. Amid tariff and macro uncertainty, agriculture has "proved a relatively resilient pocket of the market," the analyst tells investors in a research note. The firm says that while not immune to tariffs and retaliatory measures, ag's fundamental setup coming into 2025 remains intact. The potential for government subsidies helps dampen the economic impact on farmer customers, contends Oppenheimer.

See All Ratings

Valuation Metrics

The current forward P/E ratio for International Flavors & Fragrances Inc (IFF.N) is 15.22, compared to its 5-year average forward P/E of 21.56. For a more detailed relative valuation and DCF analysis to assess International Flavors & Fragrances Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Undervalued

5Y Average PE

21.56

Current PE

15.22

Overvalued PE

24.90

Undervalued PE

18.22

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Undervalued

5Y Average EV/EBITDA

15.09

Current EV/EBITDA

11.23

Overvalued EV/EBITDA

17.88

Undervalued EV/EBITDA

12.31

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Fair

5Y Average PS

2.18

Current PS

1.70

Overvalued PS

2.71

Undervalued PS

1.65